Outset Medical, Inc.
For the period ended Dec 31, 2025. Filed Feb 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 13, 2026
OM$4.12-2.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
(in thousands, except per share amounts)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $35,006 | $124,014 |
| Short-term investments | 133,940 | 34,671 |
| Accounts receivable, net | 28,329 | 35,619 |
| Inventories | 47,609 | 59,387 |
| Prepaid expenses and other current assets | 5,999 | 4,530 |
| Total current assets | 250,883 | 258,221 |
| Restricted cash | 3,829 | 3,329 |
| Property and equipment, net | 4,670 | 8,133 |
| Operating lease right-of-use assets | 4,797 | 3,940 |
| Other assets | 317 | 2,172 |
| Total assets | $264,496 | $275,795 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $554 | $3,862 |
| Accrued compensation and related benefits | 10,735 | 16,821 |
| Accrued expenses and other current liabilities | 9,433 | 8,205 |
| Accrued warranty liability | 1,374 | 1,938 |
| Deferred revenue, current | 13,795 | 12,753 |
| Operating lease liabilities, current | 1,739 | 1,799 |
| Total current liabilities | 37,630 | 45,378 |
| Accrued interest | — | 2,695 |
| Deferred revenue | 406 | 844 |
| Operating lease liabilities | 3,271 | 2,684 |
| Term loans | 96,237 | 197,375 |
| Total liabilities | 137,544 | 248,976 |
| Commitments and contingencies (Note 6) | ||
| Stockholders' equity: | ||
| Preferred Stock, $0.001 par value; 5,000 shares authorized, and no shares issued and outstanding as of December 31, 2025 and 2024 | — | — |
| Common stock, $0.001 par value; 300,000 shares authorized as of December 31, 2025 and 2024; 18,169 and 3,530 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 18 | 4 |
| Additional paid-in capital | 1,298,138 | 1,116,496 |
| Accumulated other comprehensive income | 172 | 42 |
| Accumulated deficit | (1,171,376) | (1,089,723) |
| Total stockholders' equity | 126,952 | 26,819 |
| Total liabilities and stockholders' equity | $264,496 | $275,795 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.